Alejandro M. Sancho-Garcia
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Odronextamab: a bispecific antibody for follicular lymphoma.
Journal: Expert opinion on investigational drugs
Published: June 13, 2026
Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial.
Journal: The Lancet. Haematology
Published: April 28, 2026
Phenotypic Characterisation of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-cell Lymphocytosis.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 29, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma.
Journal: HemaSphere
Published: December 28, 2025
High leptin levels independent of body mass index are associated with inflammation and poorer treatment response in patients with diffuse large B-cell lymphoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 01, 2025
Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study.
Journal: Lancet (London, England)
Published: July 15, 2025
Immunologic biomarkers of noninfectious complications and overall survival in common variable immunodeficiency.
Journal: The Journal of allergy and clinical immunology
Published: May 13, 2025
Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias.
Journal: Cell reports. Medicine
Published: February 23, 2025
Last Updated: 09/26/2026